A Rare Case of Bacteremic Community-Acquired Pneumonia Due to Pasteurella Multocida Presenting With Hemoptysis

Mohamad F Ayas1, Dima Youssef2, Leonard Johnson2

  • 1Internal Medicine, Ascension St. John Hospital, Detroit, USA.

Cureus
|May 7, 2021
PubMed

Insights

Pasteurella multocida pneumonia is rare in immunocompetent individuals. This case highlights a rare presentation of Pasteurella multocida pneumonia with hemoptysis in an otherwise healthy patient.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Pasteurella multocida (PM) is a Gram-negative bacterium frequently associated with soft tissue infections following animal bites or exposure.
  • PM pneumonia typically affects immunocompromised individuals or those with underlying health conditions, presenting a wide spectrum of pulmonary disease.

Observation:

  • This report details a rare case of PM pneumonia in an immunocompetent host.
  • The patient presented with hemoptysis, a seldom-reported symptom in PM-related pulmonary infections.

Findings:

  • This case represents the sixth documented instance of PM pneumonia presenting with hemoptysis.
  • The clinical presentation of PM pneumonia can mimic other respiratory pathogens, making diagnosis challenging.

Implications:

  • This case underscores the importance of considering PM in the differential diagnosis of pneumonia, even in immunocompetent patients presenting with unusual symptoms like hemoptysis.
  • Further research may elucidate the specific mechanisms leading to hemoptysis in PM pneumonia and identify risk factors.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
460
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
550
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
797
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
541
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
449